Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Cash from Investing Activities: 2009-2025

Historic Cash from Investing Activities for Cumberland Pharmaceuticals (CPIX) over the last 17 years, with Sep 2025 value amounting to -$690,837.

  • Cumberland Pharmaceuticals' Cash from Investing Activities fell 464.29% to -$690,837 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.7 million, marking a year-over-year decrease of 580.75%. This contributed to the annual value of $57,842 for FY2024, which is 154.73% up from last year.
  • Latest data reveals that Cumberland Pharmaceuticals reported Cash from Investing Activities of -$690,837 as of Q3 2025, which was down 341.67% from $285,864 recorded in Q2 2025.
  • Cumberland Pharmaceuticals' Cash from Investing Activities' 5-year high stood at $680,805 during Q3 2022, with a 5-year trough of -$13.5 million in Q1 2022.
  • In the last 3 years, Cumberland Pharmaceuticals' Cash from Investing Activities had a median value of -$58,186 in 2024 and averaged -$152,819.
  • Within the past 5 years, the most significant YoY rise in Cumberland Pharmaceuticals' Cash from Investing Activities was 728.95% (2022), while the steepest drop was 4,153.90% (2022).
  • Quarterly analysis of 5 years shows Cumberland Pharmaceuticals' Cash from Investing Activities stood at -$26,795 in 2021, then tumbled by 2,291.39% to -$640,772 in 2022, then soared by 140.68% to $260,639 in 2023, then slumped by 110.29% to -$26,809 in 2024, then crashed by 464.29% to -$690,837 in 2025.
  • Its last three reported values are -$690,837 in Q3 2025, $285,864 for Q2 2025, and -$1.2 million during Q1 2025.